Dr. Gyanendra Singh earned his Ph.D from Central Drug Research Institute, Lucknow, India in 2006, and moved to USA for pursuing further research in advanced areas of microbiology and molecular biology at LSU Health Sciences Center, New Orleans, LA and K-State University, Manhattan, KS. Currently he is working as a Scientist-B Molecular Toxicology, National Institute of Occupational Health, India. He is an expert in molecular biology, microbiology and virology. Dr. Gyanendra Singh’s current focus is on novel therapeutic interventions to target Epstein-Barr virus (EBV) mediated cancer/lymphomas.
Dr. Gyanendra Singh's is interested in the field of Molecular Toxicology, Molecular Biology, Infectious Disease and Cancer Biology.
